Feedback Share Discussion Threads

[ged5] 25/11/2019 13:03

Sorry Pictureframe I marked your post up by mistake.

The trial is 3 months so should be completed in February.

[ged5] 25/11/2019 12:59

Thanks for those links LR2.

I've quickly skimmed through the Visage Ease Pro user manual. It looks as though it can do almost everything that Bleepa does.

I say almost because the Visage 7 server is needed. Bleepa can be used with any DICOM conformant PACS.

All very interesting. There's obviously a call for this sort of device but it looks like Bleepa might not get an open field. My earlier calculations were based on capturing 3% of the market which should be achievable. Target price 8p. So come on Team TOM let's get some more trials and make sure they're a success.

[pictureframe] 25/11/2019 12:57

how long is the trail?

[yump] 25/11/2019 12:40

One of Bleepa's USP's is the ability to annotate the images.

I mentioned this to a consultant that I know and he said that was a big benefit.

Its only one consultant of course. Well 2 actually as another thought it sounded good a while ago. I guess we'll find out in due course after the trial(s).

[lr2] 25/11/2019 12:31

For the sake of clarity please note the following warnings.



*Note: Visage Ease is not a medical device and must not be used for diagnosis.



*Note: Visage Ease Pro includes FDA 510(k) clearance for the mobile diagnostic interpretation of all imaging modalities except mammography. Visage Ease is not a medical device and must not be used for diagnosis.



Note: Visage Ease Pro requires access to a Visage 7 server running 7.1.6 or later. Without access to a Visage 7 server, image access is not possible.

[sonie01] 25/11/2019 12:11

Still do not understand why this is not higher especially now that we have it in a trial! Got to be MMs manipulating this

[seppin] 25/11/2019 10:02

Morning Mr Brown (Regina), you get about don't you? Unlikely you are invested here but seem to take pleasure from appearing periodically to knock the company. You happy to use Texrad at IQAI? You appear to assume that Professor Shaw and Mr Oakley haven't done any due diligence with bleepa in a clinical setting, that would be remiss wouldn't it? I think it's time you let your bitterness and disagreement towards Tom Charlton go and enjoy your time in a more personally rewarding fashion. Good luck with IQAI and RMS am invested in both. Have a nice day.

[ged5] 25/11/2019 09:53

So you think Bleepa doesn't have a USP? Yes the image is available from the PACS or relevant DICOM in the many other systems. Do they do what Bleepa does?

Are you calling the CEO a liar when he states this?:-

'The USP of Bleepa is that it facilitates image based communication between frontline clinical teams through mobile devices which other vendors do not do.'

[regina61] 25/11/2019 09:37

Bleepa v Forward, many here are taking comfort from the image quality offered on Bleepa compared with Forward. However, Forward was designed around the clinical needs of the clinical teams, if the clinical needs change, for example sourcing from original images available from the relevant DICOM - why would anyone assume it couldn't be done? In fact there are many other products and offerings for example see hxxp://www.visageimaging.com/ I think you should speak to a clinician and find the truth instead of making self-serving assumptions because you are invested in Feedback. None so blind as those who won't see!

[meganxmas] 24/11/2019 19:43

This was how, in August, Tom Oakley helped me understand how Bleepa would work and where the edge comes from ...Thank you for your email. I hope the following explanation makes sense but if not then just let me know.Cadran is a Picture Archiving and Communication System (PACS), in essence a library and display tool for medical images that are stored in a format called DICOM. All imaging is handled in the DICOM format as standard, internationally. Cadran is the imaging tool that powers Bleepa and it can integrate with other PACS that are already present within a hospital, meaning that the hospital doesn't need to change out any of its existing IT infrastructure, we just bolt onto the existing system - as you say this greatly broadens the addressable market. Where a site doesn't have a PACS (i.e. India for example) Cadran can act as the sole PACS. Cadran acts as an imaging processor that allows the medical images in question to be viewed through a web app on any device.Many thanksTom

[yump] 24/11/2019 17:14

GDPR requirements and utility are two separate things, likely to be driven by two different groups of people: administrative and clinical.

Hopefully the need for more clinical detail drives the sale and gdpr is an ‘insuranceR17; check.

[lr2] 24/11/2019 16:33

Posted at 01:00 on Bleepa Twitter.



Contains a link to the following.



Application deadline was last Friday.

If anybody from Feedback end up in Chicago next April we will know why.

[czc9] 24/11/2019 15:24

Yes I get the USP but do the NHS care enough about that point if their GDPR problem is solved elsewhere?

[czc9] 24/11/2019 15:20

Very expensive sales teams which is why the cash burn is so high.

[ducatiman] 24/11/2019 14:56

But we have 2 sales teams Ged!!

[ged5] 24/11/2019 14:48

We need a dynamic sales marketing team. It's obvious there's a market just waiting for Bleepa but we need to get out there and satisfy that market instead of these amateur wannabees!

[ducatiman] 24/11/2019 14:32

And! Is our technology protected? If the answers are No and Yes then we have potentially a worldwide market for 'Bleepa'. It could get exciting, then again, lol.

[ducatiman] 24/11/2019 14:16

So, the question is:- Does 'Bleepa' have any competition? Anywhere in the world? To date nobody has been able to identify any.

[ged5] 24/11/2019 14:05

I was just checking about the connection with Leeds Hospital. Apparently it was Dr Ganeshan giving a talk chaired by Professor Andrew Scarsbrook of Leeds Teaching Hospitals NHS Trust.

I just noticed the news announcement put on the website on Friday. Nothing new, just a reminder of Professor Shaws connections.

[ged5] 24/11/2019 13:46

Exactly Megan!

[ged5] 24/11/2019 13:45

Thanks Leoboy! I seem to remember Feedback having a connection with Leeds Hospital.

[ged5] 24/11/2019 13:38

Oh for goodness sake. How many times do we have to go through this. Haven't you got it yet?

From your article:-

Through the app, NHS staff can search by name or role in a hospital or clinic, share patient notes and photos, with everyone working off the same list.

Bleepa shares clinical grade images which can be enlarged annotated and rotated.

From the CEO:-

The USP of Bleepa is that it facilitates image based communication between frontline clinical teams through mobile devices which other vendors do not do.

Thanks for your article though which shows there is a need, maybe a desperate need, for this type of technology in the NHS. Maybe Bleepa is the answer! I guess you're still interested in the story here? Regretting selling?

[leoboy] 24/11/2019 13:35

is this the competition ? :

[meganxmas] 24/11/2019 13:26

There will be many that will have similar offerings but how many can send clinical grade images for review and discussion as opposed to just pictures ... that's where bleepa wins.

[czc9] 24/11/2019 13:22

https://www.cityam.com/just-what-the-doctor-ordered-an-app-to-free-nhs-staff-of-retro-technology/A rival, with a head start?